{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:02:36Z","timestamp":1791417756928,"version":"4.3.3"},"reference-count":93,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","award":["PMID 31426129"],"award-info":[{"award-number":["PMID 31426129"]}],"id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["1K08HG010061-01A1"],"award-info":[{"award-number":["1K08HG010061-01A1"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["3UL1TR001085-04S1"],"award-info":[{"award-number":["3UL1TR001085-04S1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD021763"],"award-info":[{"award-number":["1S10OD021763"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 S10OD018220"],"award-info":[{"award-number":["1 S10OD018220"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.xcrm.2021.100425","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T05:38:12Z","timestamp":1634881092000},"page":"100425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-5438","authenticated-orcid":false,"given":"Zhu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenn","family":"Fechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Natu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0795-9946","authenticated-orcid":false,"given":"Holden","family":"Maecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0962-2215","authenticated-orcid":false,"given":"Anandi","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100425_bib92","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib94","first-page":"1","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J.\u00a0Stat. Softw"},{"key":"10.1016\/j.xcrm.2021.100425_bib83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCRESAHA.119.315215","article-title":"Longitudinal RNA-seq analysis of the repeatability of gene expression and splicing in human platelets identifies a platelet SELP splice QTL","volume":"126","author":"Rondina","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjh.16152","article-title":"Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis","volume":"188","author":"Guo","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2021.100425_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11899-013-0176-z","article-title":"Are MPNs vascular diseases?","volume":"8","author":"Finazzi","year":"2013","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.xcrm.2021.100425_bib2","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0049-3848(16)30102-5","article-title":"Molecular biomarkers of thrombosis in myeloproliferative neoplasms","volume":"140","author":"Barbui","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib3","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative Neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1403141","article-title":"Two clinical phenotypes in polycythemia vera","volume":"371","author":"Spivak","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","article-title":"Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms","volume":"129","author":"Rumi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2016.70.7968","article-title":"Genomics of Myeloproliferative Neoplasms","volume":"35","author":"Zoi","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2021.100425_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.14694\/EdBook_AM.2012.32.85","article-title":"Insights into the molecular genetics of myeloproliferative neoplasms","volume":"2021","author":"Nguyen","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.xcrm.2021.100425_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/ehm.10.28","article-title":"JAK2 V617F and beyond: Role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms","volume":"3","author":"Oh","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.xcrm.2021.100425_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Hinds","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib11","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13148-011-0050-6","article-title":"Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies","volume":"2","author":"Mascarenhas","year":"2011","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.xcrm.2021.100425_bib13","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1038\/bcj.2011.4","article-title":"Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium","volume":"1","author":"Tefferi","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2021.100425_bib14","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCRESAHA.113.300512","article-title":"Platelets as cellular effectors of inflammation in vascular diseases","volume":"112","author":"Rondina","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev-physiol-030212-183752","article-title":"Platelets in lung biology","volume":"75","author":"Weyrich","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.xcrm.2021.100425_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/asheducation-2014.1.400","article-title":"Platelets: More than a sack of glue","volume":"2014","author":"Weyrich","year":"2014","journal-title":"Hematology (Am. Soc. Hematol. Educ. Program)"},{"key":"10.1016\/j.xcrm.2021.100425_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MOH.0b013e328357010e","article-title":"Platelet mRNA: The meaning behind the message","volume":"19","author":"Rowley","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.xcrm.2021.100425_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2014-04-512756","article-title":"A tour through the transcriptional landscape of platelets","volume":"124","author":"Schubert","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib20","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1182\/blood-2013-12-544692","article-title":"Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics","volume":"123","author":"Simon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.119.313280","article-title":"Megakaryocyte and platelet tanscriptomics for discoveries in human health and disease","volume":"40","author":"Davizon-Castillo","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100425_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCRESAHA.115.308190","article-title":"Blood-derived extracellular RNA and platelet pathobiology: Adding pieces to a complex circulating puzzle","volume":"118","author":"Clancy","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4049\/jimmunol.1700885","article-title":"Granzyme A in human platelets regulates the synthesis of proinflammatory cytokines by monocytes in aging","volume":"200","author":"Campbell","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100425_bib25","doi-asserted-by":"crossref","first-page":"e44031","DOI":"10.7554\/eLife.44031","article-title":"Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets","volume":"8","author":"Cunin","year":"2019","journal-title":"elife"},{"key":"10.1016\/j.xcrm.2021.100425_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood.2019000067","article-title":"Sepsis alters the transcriptional and translational landscape of human and murine platelets","volume":"134","author":"Middleton","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3995","article-title":"Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition","volume":"21","author":"Wen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib28","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood.V120.21.2867.2867","article-title":"Aberrant megakaryocyte gene expression contributes to primary myelofibrosis","volume":"120","author":"Gilles","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood.V128.22.949.949","article-title":"Activation of JAK\/STAT signaling in megakaryocytes is necessary and sufficient for myeloproliferation in vivo","volume":"128","author":"Wen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib30","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-18-4089","article-title":"Activation of JAK\/STAT signaling in megakaryocytes sustains myeloproliferation in\u00a0vivo","volume":"25","author":"Woods","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib31","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/1078-0432.CCR-12-2604","article-title":"Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia","volume":"19","author":"Krause","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib32","first-page":"5288","article-title":"Platelet transcriptomic signatures in myeloproliferative neoplasms","volume":"130","author":"Krishnan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"Skov","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.xcrm.2021.100425_bib34","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.leukres.2012.07.009","article-title":"Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance","volume":"36","author":"Skov","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.2019000519","article-title":"Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms","volume":"134","author":"Schischlik","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/bloodadvances.2019001379","article-title":"Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia","volume":"4","author":"Gangaraju","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100425_bib38","doi-asserted-by":"crossref","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib39","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","article-title":"Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes","volume":"118","author":"Rowley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-61779-307-3_12","article-title":"A rapid and efficient platelet purification protocol for platelet gene expression studies","volume":"788","author":"Amisten","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1101\/pdb.top084970","article-title":"RNA sequencing and analysis","volume":"2015","author":"Kukurba","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.xcrm.2021.100425_bib42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","article-title":"Risk prediction models: II. External validation, model updating, and impact assessment","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.xcrm.2021.100425_bib43","first-page":"139","article-title":"The platelet transcriptome in health and disease","author":"Rowley","year":"2019"},{"key":"10.1016\/j.xcrm.2021.100425_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2019.00123","article-title":"CREB3 Transcription Factors: ER-Golgi Stress Transducers as Hubs for Cellular Homeostasis","volume":"7","author":"Sampieri","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib45","doi-asserted-by":"crossref","first-page":"32369","DOI":"10.1074\/jbc.M205269200","article-title":"Regulation of calreticulin expression during induction of differentiation in human myeloid cells. Evidence for remodeling of the endoplasmic reticulum","volume":"277","author":"Clark","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2021.100425_bib85","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100425_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2018-07-858720","article-title":"Benefits and risks of JAK inhibition","volume":"132","author":"Arcaini","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.12688\/f1000research.13167.1","article-title":"JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders","volume":"7","author":"Vainchenker","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ccell.2018.03.024","article-title":"Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100425_bib49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/leu.2013.205","article-title":"Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)","volume":"28","author":"Zhou","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2021.100425_bib50","doi-asserted-by":"crossref","first-page":"eabg0833","DOI":"10.1126\/sciimmunol.abg0833","article-title":"SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation","volume":"6","author":"Yan","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2021.100425_bib51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib52","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2014.106567","article-title":"MEIS1 regulates early erythroid and megakaryocytic cell fate","volume":"99","author":"Zeddies","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2021.100425_bib53","doi-asserted-by":"crossref","first-page":"e0183042","DOI":"10.1371\/journal.pone.0183042","article-title":"Comprehensive comparison of neonate and adult human platelet transcriptomes","volume":"12","author":"Caparr\u00f3s-P\u00e9rez","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100425_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J.\u00a0R. Stat. Soc. B"},{"key":"10.1016\/j.xcrm.2021.100425_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","article-title":"ADAMTS proteins in human disorders","volume":"71-72","author":"Mead","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib56","first-page":"2103","article-title":"PSMB5 plays a dual role in cancer development and immunosuppression","volume":"7","author":"Wang","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib57","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood.V116.21.4117.4117","article-title":"Increased expression of proteasome-related genes in patients with pimary myelofibrosis","volume":"116","author":"Skov","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib58","doi-asserted-by":"crossref","first-page":"39985","DOI":"10.1038\/srep39985","article-title":"Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate","volume":"7","author":"Moniz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100425_bib59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100425_bib60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ceb.2008.04.008","article-title":"The multi-tasking P-TEFb complex","volume":"20","author":"Br\u00e8s","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib61","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/s41598-020-61309-3","article-title":"Megakaryocytes contain extranuclear histones and may be a source of platelet-associated histones during sepsis","volume":"10","author":"Frydman","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100425_bib62","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/leu.2008.113","article-title":"Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal","volume":"22","author":"Vannucchi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2021.100425_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","article-title":"Targeted deep sequencing in polycythemia vera and essential thrombocythemia","volume":"1","author":"Tefferi","year":"2016","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100425_bib64","article-title":"Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution","author":"Williams","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.xcrm.2021.100425_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4028","article-title":"Targeting a regulator of protein homeostasis in myeloproliferative neoplasms","volume":"22","author":"LaFave","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm.4013","article-title":"Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling","volume":"22","author":"Osorio","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib67","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/1078-0432.CCR-18-3777","article-title":"Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis","volume":"25","author":"Merlinsky","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100425_bib68","doi-asserted-by":"crossref","first-page":"e0216810","DOI":"10.1371\/journal.pone.0216810","article-title":"Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures","volume":"14","author":"Wong","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100425_bib69","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2020003614","article-title":"Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis","volume":"5","author":"Rontauroli","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100425_bib70","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2012-05-432989","article-title":"Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-\u03b1 in a murine model of polycythemia vera","volume":"121","author":"Mullally","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib71","doi-asserted-by":"crossref","first-page":"14 40 11","DOI":"10.1002\/cpph.23","article-title":"Overview of transgenic mouse models of myeloproliferative neoplasms (MPNs)","volume":"77","author":"Dunbar","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100425_bib72","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1161\/ATVBAHA.120.314760","article-title":"Platelet dysfunction and thrombosis in JAK2V617F-mutated primary myelofibrotic mice","volume":"40","author":"Matsuura","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2021.100425_bib73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2021.100425_bib74","doi-asserted-by":"crossref","first-page":"284706","DOI":"10.1155\/2015\/284706","article-title":"Impact of inflammation on myeloproliferative neoplasm symptom development","volume":"2015","author":"Geyer","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.xcrm.2021.100425_bib75","doi-asserted-by":"crossref","first-page":"102476","DOI":"10.1155\/2015\/102476","article-title":"MPNs as inflammatory diseases: The evidence, consequences, and perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.xcrm.2021.100425_bib76","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.xcrm.2021.100425_bib77","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fimmu.2019.01373","article-title":"Platelets as mediators of thromboinflammation in chronic myeloproliferative neoplasms","volume":"10","author":"Marin Oyarz\u00fan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100425_bib78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hon.2622","article-title":"Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms","volume":"37","author":"Mughal","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2021.100425_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-017-0425-z","article-title":"Driver mutations (JAK2V617F, MPLW515L\/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera","volume":"10","author":"Lussana","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2021.100425_bib80","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3324\/haematol.2019.243121","article-title":"Bone marrow niche dysregulation in myeloproliferative neoplasms","volume":"105","author":"Curto-Garcia","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2021.100425_bib81","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood.2020007975","article-title":"ER-associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity","volume":"136","author":"Liu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib82","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/nm.4001","article-title":"Proteostasis and aging","volume":"21","author":"Kaushik","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100425_bib86","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib87","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2002-09-2797","article-title":"Transcript profiling of human platelets using microarray and serial analysis of gene expression","volume":"101","author":"Gnatenko","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib88","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.106.658641","article-title":"Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease","volume":"115","author":"Raghavachari","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2021.100425_bib89","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2003-05-1429","article-title":"Evaluating the relevance of the platelet transcriptome","volume":"102","author":"Weyrich","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100425_bib90","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xcrm.2021.100425_bib91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2021.100425_bib93","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:13:42Z","timestamp":1778919222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121002871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2666379121002871"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100425","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100425"}}